Newsletter Vol. 11 HIV Program Update Enrolled First Cohort Since our last Newsletter, AGT has enrolled its first cohort of six participants in its Phase 1 study of AGT103-T against HIV. Updates on the RePAIR Clinical Trial (AGT103-T) Cl...
What's Happening at American Gene
Our team personally cares about the people we serve. We make progress every day to end suffering and premature death from serious human diseases. The Newsletter is one quick way keep track of AGT's advancements on all its programs and other events happening at the company. We look forward to keeping you up to date on our mission!